How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/hiatal-hernia-with-reflux-esophagitis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-11 · How we verify

Hiatal Hernia with Reflux Esophagitis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hiatal Hernia with Reflux Esophagitis (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Hiatal Hernia with Reflux Esophagitis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Renacidin	MAGNESIUM CARBONATE	United Guardian	Vitamin C [EPC]		1990-01-01
Gaviscon	MAGNESIUM SILICATE	Sanofi	magnesium silicate		1983-01-01
Bss	SODIUM CITRATE	B Braun	sodium citrate	Calcium	1980-01-01
Milk of Magnesia	magnesium hydroxide	Generic (multiple manufacturers)	Osmotic laxative, Antacid	Gastric acid (direct neutralization) + osmotic effect in intestine	1880-01-01
Potassium Alum	Alum	Novartis Pharmaceuticals	Non-Standardized Plant Allergenic Extract [EPC]

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 2 drugs in Hiatal Hernia with Reflux Esophagitis
B Braun · 1 drug in Hiatal Hernia with Reflux Esophagitis
Generic (multiple manufacturers) · 1 drug in Hiatal Hernia with Reflux Esophagitis
Novartis Pharmaceuticals · 1 drug in Hiatal Hernia with Reflux Esophagitis
Sanofi · 1 drug in Hiatal Hernia with Reflux Esophagitis
United Guardian · 1 drug in Hiatal Hernia with Reflux Esophagitis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Hiatal Hernia with Reflux Esophagitis:

Cite this brief

Drug Landscape (2026). Hiatal Hernia with Reflux Esophagitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hiatal-hernia-with-reflux-esophagitis. Accessed 2026-06-11.

Hiatal Hernia with Reflux Esophagitis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing